DEF 14A: Alchemy Investments Acquisition Corp 1 Seeks Extension to Complete Business Combination

Alchemy Investments Acquisition Corp 1 is seeking shareholder approval to extend the deadline for completing its initial business combination from November 9, 2024, to September 9, 2025.

Summary

• Alchemy Investments Acquisition Corp 1 (ALCY) is seeking shareholder approval for an extension to complete its initial business combination.
• The company's annual general meeting is scheduled for October 24, 2024, to vote on proposals including an extension to the deadline for completing a business combination, ratification of auditors, and adjournment if necessary.
• The Extension Proposal aims to extend the deadline from November 9, 2024, to September 9, 2025.
• If approved, the sponsor, Alchemy DeepTech Capital LLC, will contribute funds to the trust account, initially the lesser of $90,000 or $0.03 per non-redeemed Public Share per month for the first three months, and then the lesser of $30,000 or $0.03 per non-redeemed Public Share per month thereafter.
• Shareholders have the right to redeem their Public Shares in connection with the vote on the Extension Proposal.
• If the Extension Proposal is not approved, the company will liquidate, and shareholders will receive a pro-rata portion of the trust account, estimated at approximately $10.92 per share as of October 7, 2024.
• The board recommends voting for the Extension Proposal, the Ratification of Auditors Proposal, and the Adjournment Proposal.
• The company is currently negotiating terms for an initial business combination with a potential target company.
• The record date for determining shareholders eligible to vote at the General Meeting is October 4, 2024.
• The company has engaged Advantage Proxy, Inc. to assist in the solicitation of proxies for the General Meeting for a fee of $8,500, plus disbursements.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the company is seeking an extension, which can be seen as a sign of difficulty in finding a target, the sponsor is contributing funds, and shareholders have redemption rights, providing some downside protection.

Positives

• The Extension Proposal, if approved, provides ALCY with additional time to complete a business combination, potentially leading to a successful merger and value creation for shareholders.
• The sponsor's commitment to contribute funds to the trust account demonstrates their confidence in finding a suitable target and completing a business combination.
• Shareholders retain the right to redeem their Public Shares if they do not support the extension, providing them with a return of capital.
• The board's recommendation to vote for the Extension Proposal suggests they believe it is in the best interest of the company and its shareholders.

Negatives

• If the Extension Proposal is not approved, the company will liquidate, resulting in shareholders receiving a pro-rata portion of the trust account, which may be less than the initial investment.
• The potential for redemptions by shareholders who do not support the extension could reduce the amount of capital available for a business combination.
• The sponsor's contributions are structured as loans, which will need to be repaid upon consummation of a business combination, potentially impacting the financial performance of the combined company.
• The company has already been searching for a target for a significant period, and there is no guarantee that an extension will result in a successful business combination.

Risks

• The company may not be able to complete a business combination even with the extension.
• Shareholder redemptions could significantly reduce the funds available in the trust account.
• The sponsor's loans to the company may not be repaid if a business combination is not completed.
• The company could be deemed an investment company, forcing liquidation.
• A potential business combination with a U.S. target company may be subject to U.S. foreign investment regulations and review by a U.S. government entity such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited.

Future Outlook

The company intends to continue seeking a business combination until the Extended Date, or until the Board determines it will not be able to consummate a business combination and does not wish to seek an additional extension.

Management Comments

• The Board believes shareholders will benefit from the Companys consummating the Proposed Business Combination and is proposing the Extension Proposal to extend the date by which the Company has to complete the Proposed Business Combination.
• The board of directors currently believes that there will not be sufficient time before the Current Termination Date to complete its Proposed Business Combination and hold a general meeting at which to conduct a vote for shareholder approval of the Proposed Business Combination.
• Accordingly, our board of directors has determined it is in the best interests of the Company and our shareholders to extend the termination date from the Current Termination Date to the Extended Date.

Industry Context

This announcement is typical for SPACs approaching their initial business combination deadline, as they often seek extensions to provide more time to identify and complete a suitable merger. The need for an extension highlights the challenges in finding appropriate targets within the initial timeframe.

Comparison to Industry Standards

• Many SPACs, such as Gores Metropoulos II, Inc. (GMII) and Churchill Capital Corp VII (CVII), have sought and obtained extensions to complete their business combinations.
• The contribution of funds by the sponsor to the trust account is a common practice to incentivize shareholders to approve the extension, similar to what was done by Pershing Square Tontine Holdings, Ltd. (PSTH).
• The redemption rights offered to shareholders are standard in SPAC extension votes, providing an option for those who do not wish to continue with the extended timeline, as seen in the case of Social Capital Hedosophia Holdings Corp V (IPOE).

Related Party Transactions

• The sponsor, Alchemy DeepTech Capital LLC, has agreed to provide funds to the Company to extend the period of time to consummate a business combination.

Stakeholder Impact

• Shareholders have the right to redeem their Public Shares if they do not support the extension.
• If the Extension Proposal is not approved, shareholders will receive a pro-rata portion of the trust account.
• The sponsor and ALCYs officers and directors and their affiliates are entitled to reimbursement of out-of-pocket expenses incurred by them in connection with certain activities on ALCYs behalf, such as identifying and investigating possible business targets and business combinations.

Next Steps

• Shareholders will vote on the Extension Proposal, the Ratification of Auditors Proposal, and the Adjournment Proposal at the General Meeting on October 24, 2024.
• If the Extension Proposal is approved, the company will continue to seek a business combination until the Extended Date.
• If the Extension Proposal is not approved, the company will liquidate.

Key Dates

Keywords

business combination, extension proposal, special purpose acquisition company, SPAC, redemption rights, liquidation, trust account, proxy statement, shareholders, ALCY, Alchemy Investments Acquisition Corp 1